Atea Pharmaceuticals, Inc.
AVIR· Nasdaq
Released May 9, 2022, after the close
10-Q filed May 10, 2022, 40 days after period end · 0000950170-22-008732
| Metric | Q1 2022 | Q1 2021 | Q1 2020 | Q1 2019 |
|---|---|---|---|---|
| Revenue | — | $65.99M | — | — |
| Net Income | -$42.08M | $30.71M | -$3.99M | -$2.19M |
| EPS Diluted |
Atea Pharmaceuticals, Inc. · CIK 1593899 · Engraved from SEC EDGAR
| -$0.51 |
| $0.34 |
| -$0.40 |
| — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.